Navigation Links
Catalent Receives P&G External Business Partner of the Year Award
Date:2/19/2019

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the External Business Partner of the Year Award.

The award recognizes the performance of Catalent’s two state-of-the-art softgel manufacturing facilities in Ontario, Canada which have been supplying P&G Personal Healthcare brands in the U.S. and Canada. Catalent also launched additional cough and cold OTC product line extensions with P&G in 2018, which are supplied from Catalent’s facilities in Ontario.

“Catalent has been P&G’s preferred softgel supplier for twenty years,” commented Dr. Aris Gennadios, President, Catalent Softgel Technologies. He added, “We continue to collaborate closely with P&G Personal Healthcare to bring innovative products to consumers.”

“I congratulate and thank all of our award winners. They are critical partners in accomplishing our purpose,” said Stew Atkinson, Chief Purchasing Officer, P&G. “P&G’s supplier eco-systems are creating value for consumers, customers, P&G and our suppliers. I am proud of what we have accomplished, and we will continue to raise the bar on superiority, productivity and citizenship together.”

Catalent’s Ontario facilities in Strathroy and Windsor offer softgel development and manufacturing capabilities for both the pharmaceutical and consumer health industries. The two sites combine integrated formulation, manufacturing, analytical and packaging services to provide full service turnkey solutions to partners.

For more information, please see Procter & Gamble’s press release: https://news.pg.com/press-release/pg-corporate-announcements/pg-recognizes-top-suppliers-powering-global-supply-network-

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/catalent_receives_p_g_external_business_partner_of_the_year_award/prweb16108054.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
2. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
3. NDA Partners Expert Consultant Vinod Shah, PhD, Receives AAPS Award for Global Leadership
4. EARTHRES Vice President Louis F. Vittorio, Jr., P.G., Receives IBWA Advocacy Award
5. FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format
6. Captiva Spine Receives Clearance to Market TowerLOX-EXT MIS Extended Tab Pedicle Screw
7. EyeLock Receives Patent for Sequentially Linking Iris Matching With Facial Imaging
8. Genos receives CAP Accreditation for Meeting the Highest Standards in Laboratory Practices
9. FST Biometrics Receives a Visionary Award from Frost & Sullivan for Leading the Market in Biometrics-based In Motion Identification
10. SRI International Receives $9 Million Contract to Support National Cancer Institute PREVENT Cancer Program
11. FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2020)... ... July 16, 2020 , ... ... the effectiveness of the Invictus Medical Neoasis™ active noise control device to attenuate ... reported that the Neoasis™ device attenuated the alarm sounds from patient monitors, ventilators ...
(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for ... Point of Care Testing solutions (POCT). Check local listings for more info. , Today, ... offices and are shipped to labs throughout the country. Results are then available several ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... Medial EarlySign ... detection and prevention of high-burden diseases, and Centric Consulting, a business and technology ... to utilize existing data in order to identify and prioritize patients for care. ...
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
Breaking Biology Technology: